University of Kassala Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01625871
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

University of Kassala, Sudan

Active Ingredients

Drugs in Phase 4 Trials (2)

artesunate (1 trial)

quinine (qualaquin) (1 trial)

Drugs in Phase 3 Trials (2)

coartem (1 trial)

lumefantrine (Coartem) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Malaria, Vivax (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4